Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 6 | 0 | 6 |
| 2002 | 1 | 1 | 2 |
| 2003 | 8 | 3 | 11 |
| 2004 | 6 | 2 | 8 |
| 2005 | 9 | 3 | 12 |
| 2006 | 3 | 3 | 6 |
| 2007 | 4 | 2 | 6 |
| 2008 | 3 | 2 | 5 |
| 2009 | 5 | 2 | 7 |
| 2010 | 3 | 3 | 6 |
| 2011 | 12 | 9 | 21 |
| 2012 | 4 | 2 | 6 |
| 2013 | 8 | 0 | 8 |
| 2014 | 6 | 4 | 10 |
| 2015 | 4 | 2 | 6 |
| 2016 | 15 | 8 | 23 |
| 2017 | 11 | 7 | 18 |
| 2018 | 8 | 4 | 12 |
| 2019 | 7 | 6 | 13 |
| 2020 | 11 | 3 | 14 |
| 2021 | 10 | 2 | 12 |
| 2022 | 17 | 0 | 17 |
| 2023 | 5 | 0 | 5 |
| 2024 | 13 | 1 | 14 |
| 2025 | 11 | 6 | 17 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing. Nat Commun. 2026 Jun 11; 17(1).
-
Noninvasive diagnosis of pulmonary tuberculosis using face mask sampling: a prospective study in adults. Clin Microbiol Infect. 2026 Apr; 32(4):644-649.
-
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiol Spectr. 2026 Jan 06; 14(1):e0233525.
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2025 10 23; 10:CD013359.
-
Self-powered rapid antigen-specific T-cell response assay for Mycobacterium tuberculosis infections. Nat Biomed Eng. 2026 Jan; 10(1):69-79.
-
Performance of a Novel Stool Quantitative Polymerase Chain Reaction Assay for Pediatric Tuberculosis Detection in Sub-Saharan Africa. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
-
Perceived usability, acceptability, and feasibility of stool-based qPCR TB diagnostics: perspectives from healthcare providers in Manhi?a District, southern Mozambique. BMC Infect Dis. 2025 May 26; 25(1):757.
-
Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study. Lancet Microbe. 2025 07; 6(7):101085.
-
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis. Tuberculosis (Edinb). 2025 May; 152:102619.
-
High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered? Infection. 2025 Aug; 53(4):1501-1506.